On March 17, 2026, a high-level workshop on modern skin cancer diagnostics took place at Hautwerk Zurich. The event focused on Electrical Impedance Spectroscopy EIS and the innovative Nevisense system, highlighting the growing importance of advanced technologies in dermatology and skin cancer screening.
The workshop was a great success and emphasized the increasing relevance of early skin cancer detection in Switzerland, particularly in light of rising melanoma and skin cancer rates.
Growing Importance of Skin Cancer Detection in Switzerland
Numerous dermatologists attended the workshop to gain insights into the latest developments in skin cancer diagnosis and early detection. With increasing incidence rates of melanoma and other skin cancers in Switzerland, the topic is becoming more important than ever.
Data from NICER and the Federal Statistical Office confirm the upward trend, underlining the need for innovative diagnostic solutions and continuous medical education.
Practical Insights and Latest Clinical Research
Led by Bernd Schmiedl, Key Account Manager at SciBase for Switzerland, Austria, and the Balkan region, the workshop provided in-depth knowledge of:
- clinical study data on EIS technology
- functionality of Electrical Impedance Spectroscopy
- practical application in dermatology practices
Participants particularly valued the combination of scientific expertise and hands-on demonstration. The opportunity to test the Nevisense system and discuss real clinical cases made the workshop highly relevant for everyday dermatological practice.
All content was based on the latest dermatological research and clinical experience.
Innovative Skin Cancer Diagnostics with EIS and Nevisense
A central topic of the workshop was how innovative diagnostic technologies can improve the assessment of suspicious skin lesions.
Electrical Impedance Spectroscopy enables an additional evaluation of pigmented lesions and supports dermatologists in making more informed clinical decisions.
The Nevisense system demonstrated its ability to increase sensitivity in melanoma detection, making it a valuable tool in modern dermatology. At the same time, experts emphasized that such technologies support, not replace, medical expertise.
Early detection remains critical, as melanoma diagnosed at an early stage can often be treated successfully.
Nevisense in Zurich: Access to Advanced Skin Cancer Screening
Patients in Zurich already have access to modern skin cancer diagnostics using Nevisense in selected dermatology clinics, including:
Hautwerk AG
Dr. Bettina Rümmelein
Maneggstrasse 17
CH 8041 Zurich
www.hautwerk.ch
Stefan Teske Hautzentrum AG
Birmensdorferstrasse 1
CH 8004 Zurich
www.hautarzt-teske.ch
This ensures access to advanced melanoma screening and early detection technologies directly in Zurich.
Continuing Medical Education in Dermatology
The workshop clearly demonstrated that continuous education in dermatology is essential in response to rising skin cancer cases.
Modern diagnostic technologies such as EIS contribute to:
- improved diagnostic accuracy
- better clinical decision-making
- increased patient safety
Participants showed strong interest in integrating these technologies into their own practices and clinics.
Conclusion: Future of Skin Cancer Diagnostics in Switzerland
The workshop at Hautwerk Zurich set an important benchmark for the future of skin cancer diagnostics in Switzerland.
The combination of expert exchange, practical training, and innovative technology made the event highly valuable for dermatologists.
As the importance of early skin cancer detection continues to grow, such workshops play a key role in advancing quality, innovation, and patient safety in dermatology.
Sources
University Hospital Zurich, Malignant Melanoma
https://www.usz.ch/krankheit/melanom/
Swiss Cancer League, Skin Cancer
https://www.krebsliga.ch/ueber-krebs/krebsarten/hautkrebs/
National Institute for Cancer Epidemiology and Registration NICER
https://www.nicer.org
Federal Statistical Office, Cancer Statistics
https://www.bfs.admin.ch
MedizinOnline, Dermatological Developments
https://medizinonline.com/en/experience-of-the-last-years/
Further Information
SciBase
https://scibase.com
Nevisense
https://nevisense.de
